LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today ...
LOS ANGELES, Oct. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today ...
Hosted on MSN
Enochian: The Mysterious Lost Language of ANGELS
Could humanity once speak the language of angels? Enochian, a mysterious and ancient tongue, is believed to be the divine language revealed to 16th-century mystics. Discover its origins, the cryptic ...
Enochian Biosciences is a pre-clinical stage biotech that purchased its HIV drug IP from Weird Science, LLC. ENOB's lead scientist and HIV IP inventor does not appear to have any biotech experience, ...
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and ...
It's not every day that a biotech's scientific co-founder is arrested on murder-for-hire charges. But the aftermath of that arrest is just what Enochian Biosciences' CEO faces now—and he's fighting ...
Enochian BioSciences (NASDAQ:ENOB) on Monday said the company has achieved full compliance with Nasdaq filing requirements. The company said it regained compliance by filing its annual report on form ...
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback